James R. Porter
Expertise in
19
conditions

Dr. James R. Porter

Urology
1101 Madison Street, Suite 1400, 
Seattle, WA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
19
conditions
1101 Madison Street, Suite 1400, 
Seattle, WA 

Overview

Dr. Porter provides state-of-the-art, minimally invasive treatment options to patients with urologic cancer and stone disease to reduce the pain and recovery from surgical treatment. He stays current on the latest available treatments by teaching at national and international urologic meetings as well as publishing his outcomes. Dr. Porter was the 2023 recipient of the Menon Award in Robotic Urologic Surgery.

Dr. Porter is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Wilms Tumor, Nephrectomy, and Vasectomy.

Dr. Porter is board certified in American Board Of Urology. He is actively involved in clinical research, co-authoring 140 peer reviewed articles and participating in 2 clinical trials. Dr. Porter is currently accepting new patients.

Specialties

Urology

Licenses

Urology in WA

Board Certifications

American Board Of Urology

Hospital Affiliations

Swedish Medical Center
Jefferson Healthcare
Providence St Peter Hospital
Olympic Medical Center

Languages Spoken

English
Castilian
Punjabi
Spanish
Vietnamese

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Prominence Health
  • EPO
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

1101 Madison Street, Suite 1400, Seattle, WA 98104
Other Locations
Swedish First Hill
747 Broadway, Seattle, WA 98122
Swedish Cherry Hill
500 17th Avenue, Seattle, WA 98122

Additional Areas of Focus

Dr. Porter has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Penile Cancer
Prostatectomy
Prostate Cancer
Bladder Cancer
Testicular Cancer
Ureteroscopy
Nephrectomy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer
SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 24, 2026
Intervention Type: Drug, Procedure, Other
Study Drugs: Antiandrogen therapy, Docetaxel
Study Phase: Phase 2
Feasibility of Cytoreductive Prostatectomy in Men Newly Diagnosed With Metastatic Prostate Cancer
Feasibility of Cytoreductive Prostatectomy in Men Newly Diagnosed With Metastatic Prostate Cancer
Enrollment Status: Completed
Publish Date: April 08, 2021
Intervention Type: Other, Procedure, Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

140 Total Publications

Oncological outcomes of radical nephroureterectomy with or without lymphadenectomy and neoadjuvant therapy in cN+ UTUC: Insights from the ROBUUST registry.
Oncological outcomes of radical nephroureterectomy with or without lymphadenectomy and neoadjuvant therapy in cN+ UTUC: Insights from the ROBUUST registry.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: May 27, 2026
Similar Doctors
Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

Urology Clinic At UW Medical Center - Montlake

1959 NE Pacific St, 
Seattle, WA 
 (2.9 miles away)
206-829-4211
Languages Spoken:
English, Amharic, Castilian, Romanian, Russian, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

John Gore is a Urologist practicing medicine in Seattle, Washington. Dr. Gore is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Gore is currently accepting new patients.

Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required

Urology Clinic At Harborview

908 Jefferson St, 
Seattle, WA 
 (0.3 miles away)
206-829-4211
Languages Spoken:
English, Tongan
See accepted insurances
Accepting New Patients
Offers Telehealth

Sarah Psutka is a Urologist practicing medicine in Seattle, Washington. Dr. Psutka is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy. Dr. Psutka is currently accepting new patients.

Expertise in
21
conditions
Expertise in
21
conditions
Referral may be required

Urology Clinic At UW Medical Center - Montlake

1959 NE Pacific St, 
Seattle, WA 
 (2.9 miles away)
206-829-4211
Languages Spoken:
English, Castilian, Filipino, French, Hindi, Mandarin, Romanian, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Lin is a Urologist practicing medicine in Seattle, Washington. Dr. Lin is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Cystectomy. Dr. Lin is currently accepting new patients.

Frequently Asked Questions about Dr. James R. Porter

How do I make an appointment with Dr. James R. Porter?

You can book an appointment with Dr. James R. Porter by calling their office at 206-386-6266. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. James R. Porter a top-rated expert for Renal Cell Carcinoma (RCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. James R. Porter is classified as an Elite expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. James R. Porter specialize in?

While Dr. James R. Porter is a Urology, they have specific expertise in Renal Cell Carcinoma (RCC), Nephrectomy, and WT1-Related Wilms Tumor Syndromes. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. James R. Porter participate in research or clinical trials?

Yes. Dr. James R. Porter has published 140 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. James R. Porter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. James R. Porter accept my insurance?

Dr. James R. Porter accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 206-386-6266 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Porter's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 11 Advanced Conditions
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile